Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
about
Novel treatment options for portal hypertension.Advances in the treatment of portal hypertension in cirrhosis.Effects of an intensive lifestyle intervention program on portal hypertension in patients with cirrhosis and obesity: The SportDiet study.Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase.Metformin attenuates motility, contraction, and fibrogenic response of hepatic stellate cells in vivo and in vitro by activating AMP-activated protein kinase.Comparison of Two Protocols of Carbon Tetrachloride-Induced Cirrhosis in Rats - Improving Yield and Reproducibility.
P2860
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
@en
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
@nl
type
label
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
@en
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
@nl
prefLabel
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
@en
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats.
@nl
P2093
P2860
P50
P356
P1476
Metformin reduces hepatic resistance and portal pressure in cirrhotic rats
@en
P2093
Erica Lafoz
Héctor García-Calderó
Jaime Bosch
Shiv K Sarin
P2860
P304
P356
10.1152/AJPGI.00010.2015
P577
2015-07-02T00:00:00Z